Halozyme Therapeutics, Inc. HALO
$93.09
+0.06%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 4 Hold · 0 Sell)
- Average Price Target
- $115.67
- Implied Upside
- +24.2%
- Price Target Range
- $81.00 – $149.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-20 | JP MorganJessica Fye |
Maintains | Neutral | $79 → $81 |
| 2026-11-20 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $130 |
| 2026-11-11 | Morgan StanleyVikram Purohit |
Downgrades | Overweight → Equal-weight | $105 → $109 |
| 2026-11-06 | Leerink PartnersDavid Risinger |
Downgrades | Outperform → Market perform | $110 → $117 |
| 2026-11-06 | CitizensJason N. Butler |
Maintains | Market outperform | $93 → $149 |
| 2026-11-06 | Evercore ISI GroupMichael DiFiore |
Maintains | Outperform | $123 → $125 |
| 2026-11-06 | Wells FargoMohit Bansal |
Maintains | Equal-weight | $95 → $110 |
| 2026-11-03 | JP MorganJessica Fye |
Maintains | Neutral | $78 → $79 |
| 2026-10-13 | TD CowenBrendan Smith |
Maintains | Buy | $105 → $130 |
| 2026-10-08 | JP MorganJessica Fye |
Maintains | Neutral | $70 → $78 |
| 2026-10-08 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $115 → $130 |
| 2026-09-02 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $115 |
| 2026-08-07 | Leerink PartnersDavid Risinger |
Upgrades | Market perform → Outperform | $83 → $110 |
| 2026-08-07 | TD CowenBrendan Smith |
Maintains | Buy | $96 → $105 |
| 2026-08-07 | CitizensJason N. Butler |
Maintains | Market outperform | $92 → $93 |
| 2026-08-07 | Wells FargoMohit Bansal |
Maintains | Equal-weight | $75 → $95 |
| 2026-08-07 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $95 → $115 |
| 2026-07-21 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $95 |
| 2026-05-12 | Morgan StanleyVikram Purohit |
Maintains | Overweight | $96 → $93 |
| 2026-04-29 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $90 → $95 |
| 2026-02-19 | BenchmarkRobert Wasserman |
Maintains | Buy | $75 → $90 |
| 2026-02-19 | Wells FargoMohit Bansal |
Maintains | Equal-weight | $65 → $75 |
| 2026-01-08 | TD CowenBrendan Smith |
Maintains | Buy | $79 → $90 |
| 2025-12-19 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $90 |
| 2025-11-28 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $90 |
| 2025-11-18 | Goldman SachsGraig Suvannavejh |
Maintains | Neutral | $54 → $56 |
| 2025-11-04 | CitizensJason Butler |
Maintains | Market outperform | $91 → $92 |
| 2025-10-27 | JP MorganJessica Fye |
Maintains | Neutral | $63 → $65 |
| 2025-10-20 | Morgan StanleyVikram Purohit |
Maintains | Overweight | $80 → $79 |
| 2025-10-15 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $90 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $93.09
- Market Cap
- $10.61 billion
- 52-Week Range
- $61.23 – $134.00
- Average Volume
- 2.30 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
